Q1 FY27 results: revenue down 8.5% YoY, profit falls nearly 60%

Revenue declinedEBITDA margin compressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.5%Reaction day

₹27.25

prior close

₹28.75

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+4.2% vs market

Pharmaceuticals peers, median of 163sector+0.9%+4.6% vs sector

On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 4.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

+0.0

15m

+0.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.5+1.3+4.2+0.9+4.6

Next day

-3.9+1.8-5.6+0.8-4.7

-7.9+3.1-11.0+0.3-8.2

-11.9+3.5-15.4+0.7-12.7

-12.3+3.5-15.7+1.5-13.7

-0.4+3.4-3.8+1.3-1.7

-0.9+3.6-4.6+1.6-2.6

15d

-8.3+4.9-13.1+0.9-9.1

+7.1+4.4+2.7+1.6+5.5

+17.4+2.9+14.5+1.5+16.0

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unjha Formulations posted Q1 FY27 (quarter ended June 30, 2026) results with revenue from operations of Rs. 330.75 lakhs, down about 8.5% YoY from Rs. 361.41 lakhs. Net profit fell sharply to Rs. 15.69 lakhs from Rs. 38.99 lakhs, a drop of nearly 60%. Basic EPS stood at Rs. 0.35 versus Rs. 0.87 last year. Total expenses eased to Rs. 314.98 lakhs. Auditors CA Jain and Golechha issued a clean limited review with no qualifications or adverse remarks.

Likely market impact

Weak quarter — top line and bottom line both contracted sharply. Cost savings were not enough to offset the steep profit slump.